$100M Expansion Of Pharmaceutical Operations Set For Indiana

Associated Press

The state of Indiana and the city of Bloomington announced Monday that Somerset, New Jersey-based Catalent Inc. plans a "significant expansion."
*Nyttend/public domain*

BLOOMINGTON, Ind. (AP) — A company is moving forward on a $100 million expansion of its pharmaceutical manufacturing operations in southern Indiana.

The state of Indiana and the city of Bloomington announced Monday that Somerset, New Jersey-based Catalent Inc. plans a "significant expansion" of its manufacturing of biologics, which are drugs made from living cells instead of chemicals. The expansion in Bloomington includes creating up to 200 new jobs by the end of 2024.

The maker of drug delivery technologies is working to expand drug substance manufacturing capacity and other capacity due to projected growth.

Catalent already employs about 900 people in Bloomington.

The Indiana Economic Development Corp. has offered Catalent up to $2.4 million in conditional tax credits based on the company's job creation plans. The city of Bloomington is considering additional incentives.

Tags:Bloomington pharmaceuticals Indiana Economic Development Corp.

Support independent journalism today. You rely on WFYI to stay informed, and we depend on you to make our work possible. Donate to power our nonprofit reporting today. Give now.

Indianapolis budget for 2025 proposes $1.6 billion in spending

The proposed 2025 Indianapolis budget includes a lot of things, traffic safety, gun violence reduction and housing that totals more than $1.6 billion.

Public Affairs / July 24, 2024

Kamala Harris hits campaign trail with speech in Indianapolis at national sorority gathering

Indiana was one of the first stops for presumptive Democratic presidential nominee Kamala Harris. At the sold-out event Harris told the crowd that voters will have a choice between two different visions of America.

Public Affairs / July 14, 2024

The Secret Service is investigating how a gunman who shot and injured Trump was able to get so close

The U.S. Secret Service is investigating how a gunman armed with an AR-style rifle was able to get close enough to shoot and injure former President Donald Trump at his rally in Pennsylvania.